- Home
- KLXE vs MAIA Comparison
KLXE vs MAIA Comparison
Compare KLXE & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLXE
- MAIA
- Stock Information
- Founded
- KLXE 2018
- MAIA 2018
- Country
- KLXE United States
- MAIA United States
- Employees
- KLXE N/A
- MAIA N/A
- Industry
- KLXE Oilfield Services/Equipment
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- KLXE Energy
- MAIA Health Care
- Exchange
- KLXE Nasdaq
- MAIA Nasdaq
- Market Cap
- KLXE 90.4M
- MAIA 62.4M
- IPO Year
- KLXE N/A
- MAIA 2022
- Fundamental
- Price
- KLXE $4.51
- MAIA $2.82
- Analyst Decision
- KLXE Hold
- MAIA
- Analyst Count
- KLXE 1
- MAIA 0
- Target Price
- KLXE $4.50
- MAIA N/A
- AVG Volume (30 Days)
- KLXE 92.5K
- MAIA 60.0K
- Earning Date
- KLXE 11-04-2024
- MAIA 11-05-2024
- Dividend Yield
- KLXE N/A
- MAIA N/A
- EPS Growth
- KLXE N/A
- MAIA N/A
- EPS
- KLXE N/A
- MAIA N/A
- Revenue
- KLXE $769,700,000.00
- MAIA N/A
- Revenue This Year
- KLXE N/A
- MAIA N/A
- Revenue Next Year
- KLXE $3.17
- MAIA N/A
- P/E Ratio
- KLXE N/A
- MAIA N/A
- Revenue Growth
- KLXE N/A
- MAIA N/A
- 52 Week Low
- KLXE $4.18
- MAIA $0.82
- 52 Week High
- KLXE $12.13
- MAIA $5.99
- Technical
- Relative Strength Index (RSI)
- KLXE 33.44
- MAIA 50.98
- Support Level
- KLXE $4.31
- MAIA $2.36
- Resistance Level
- KLXE $4.59
- MAIA $2.72
- Average True Range (ATR)
- KLXE 0.31
- MAIA 0.22
- MACD
- KLXE -0.05
- MAIA 0.02
- Stochastic Oscillator
- KLXE 8.92
- MAIA 72.28
About KLXE KLX Energy Services Holdings Inc.
KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.